Huang James
Director
PurchaseAlert
- Shares
- 150,000
- Price
- $2.48
- Value
- $371,610
SEC EDGAR · Forms 3/4/5Updated through Oct 30, 2026•16 filings
CNTB
Connect Biopharma Holdings Ltd
No net buying or selling imbalance over the last 3 months
No net buyers or sellers account for the net balance. There is no cluster of three distinct buyers within 30 days. We found no CEO/CFO purchases over 12 months.
How to read this signal
Only open-market P purchases and S sales count toward the signal. Vesting, options, taxes and gifts remain in the source data but do not trigger alerts. Rule 10b5-1 trades are shown as informational.
3-month balance
$0.00
0 buyers · 0 sellers
12-month purchases
$4,373,610
1 distinct insiders
12-month sales
$0.00
0 distinct insiders
Highlighted alerts
2
0 Rule 10b5-1 trades treated as informational
Buying cluster · 30 days
Fewer than three distinct buyers
CEO/CFO purchases · 12 months
No executive purchases found
Get CNTB insider trades by API
The same filtered trades as JSON for your scripts, alerts or AI agent, for 5,500+ US companies — plus sentiment, news, financials and breakout setups. Free · every API · 1,000 requests a month · no card required.
CNTB overview: breakout setup, X sentiment and insiders in one page →
Form 4 raw → Raspberry
The value is in what we do not call a signal.
The SEC XML stores every transaction. Raspberry keeps that evidence, reads the footnotes and separates voluntary open-market activity from vesting, option exercises, gifts, tax withholding, stock purchase and dividend reinvestment plans and pre-programmed 10b5-1 trades.
8
Raw transactions
Everything returned by the filing
2
Voluntary view
P/S trades after deterministic checks
6
Administrative noise
Stored, never alerted
0
10b5-1
Shown as informational
SEC ownership XML facts
- Code
- A
- Shares
- 5,000
- Price
- $0.00
- Footnotes
- 1
In accordance with the Connect Biopharma Holdings Limited Non-Employee Director Compensation Program, Dr. Xanthopoulos elected to receive fully vested shares in lieu of a portion of cash compensation for his 2026 annual board retainers. Accordingly, the fully vested ordinary shares were granted to Dr. Xanthopoulos for his service as a director during the third quarter of 2026. The number of shares received in lieu of cash was calculated by dividing the applicable value of the equity by the average closing price of our ordinary shares for the 30 days preceding September 30, 2026, rounded down to the nearest whole share.
Recent transactions
Voluntary purchases and sales; administrative noise stays hidden.
Huang James
Director
PurchaseAlert
- Shares
- 1,160,000
- Price
- $3.45
- Value
- $4,002,000
“Alert” means a voluntary, unscheduled transaction according to the filing; it is not an investment recommendation. Official source: SEC EDGAR.